首页 | 本学科首页   官方微博 | 高级检索  
     

序贯抗凝治疗缺血性脑血管病的临床疗效
引用本文:高晓红,乔淑冬,周建文. 序贯抗凝治疗缺血性脑血管病的临床疗效[J]. 中国医药, 2006, 1(9): 531-532
作者姓名:高晓红  乔淑冬  周建文
作者单位:100041,北京,北京大学首钢医院神经内科
摘    要:目的 探讨序贯抗凝治疗缺血性脑血管病的临床疗效。方法 40例频繁发生的短暂性脑缺血发作及进展性卒中患者,均经一般抗凝等治疗病情继续进展,给予口服华法林抗凝,进行疗效评价。结果 40例患者痊愈率45%;显效率25%;好转率20%,无效率10%。结论 临床序贯抗凝治疗缺血性脑血管病,治愈好转率高,后遗症少,是值得临床广泛应用的一种可行的治疗方法。

关 键 词:缺血性脑血管病 华法林 序贯抗凝
文章编号:1673-4777(2006)09-0531-02
收稿时间:2006-03-01
修稿时间:2006-03-01

Clinical therapeutic effect of sequential anti-coagulation therapy for ischemic cerebral vascular disease
Gao Xiaohong,Qiao Shudong,Zhou Jianwen. Clinical therapeutic effect of sequential anti-coagulation therapy for ischemic cerebral vascular disease[J]. China Medicine, 2006, 1(9): 531-532
Authors:Gao Xiaohong  Qiao Shudong  Zhou Jianwen
Abstract:Objective To study the clinical therapeutic effect of sequential anti-coagulation therapy for ischemic cerebral vascular disease.Methods 40 frequent transient ischemic attact(TIA) or progressive ischemic stroke patients were studied.All the patients were given general anti-coagulation and other common therapy as well as oral uarfarin.The effects were compared.Results Of all the 40 patients,45% patients recovered completely,25% improved obviously,20% improved and 10% had no effects.Conclusion Comparing with general treatment,sequential anti-coagulation therapy can obtain a higher recovery rate when treating the patients with ischemic cerebral vascular disease and less sequels,so it may worth being widely used clinically.
Keywords:Ischemic cerebral vascular disease   Uarfarin   Sequential anti-coagulation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号